big pharma will be in on the cardiovascular indication as the condition has treatments but NYR is a new drug class and patented that is showing already signs that it is far superior then current FDA first line treatments. More news flow will follow after Walter Reed for sure
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)